Evaluation the effect of standardized ginseng extract on glycated hemoglobin levels and inflammatory biomarkers in patients with diabetes type 2.

The effects of standardized ginseng extract panaxs (G115 ®) on inflammatory biomarkers and glycated hemoglobin in patients with diabetes type 2: double blind randomized placebo controlled trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013040812949N1

Enrollment

Registered

2013-05-25

Start date

2012-11-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus type 2. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: ginseng extract group will receive 300 mg of standardized ginseng extract(G115) three times a day and every time 100 mg , 30 minutes before breakfast , lunch and dinner. Intervention 2

Placebo

ginseng extract group will receive 300 mg of standardized ginseng extract(G115) three times a day and every time 100 mg , 30 minutes before breakfast , lunch and dinner

placebo group will receive placeb0(1g Wheat flour) three times a day and every time 100 mg , 30 minutes before breakfast , lunch and dinner

Eligibility

Sex/Gender

All

Age

40 Years to 60 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: age between 40 to 60 years, Minimum 2 years experience in diabete, Receiving medication to control blood sugar, Blood glucose=126mg/dl exclusion criteria: need to injection insulin, smoking, Pregnancy and lactation, Consumption Non-steroidal anti-inflammatory drugs, Diuretics, Corticosteroids

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
HBA1C %. Timepoint: before and after 8 weeks intervention. Method of measurement: percent of HBA1C.	—

Secondary

Measure	Time frame
Inflammatory biomarkers. Timepoint: before and after 8 weeks intervention. Method of measurement: IL6,hsCRP,TNF.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMeysam Alipour

Ahvaz Jundishapur University of Medical Sciences

Alipour.m@ajums.ac.ir+98 61 1444 6216

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026